Larson Anna, Shanmugam Priya, Mitrovich Rachel, Vohra Divya, Lansdale Aimee J, Eiden Amanda L
Global Vaccines Public Policy, Merck & Co., Inc, Rahway, NJ, USA.
Mathematica, Princeton, NJ, USA.
Hum Vaccin Immunother. 2025 Dec;21(1):2463732. doi: 10.1080/21645515.2025.2463732. Epub 2025 Mar 2.
Vaccination is a successful public health intervention; however, vaccine-preventable diseases continue to pose global health risks due to insufficient uptake. Expanding authority for "alternative" or complementary healthcare providers to administer vaccinations, as well as approving additional non-clinical vaccination sites, could improve access to and uptake of vaccines. The value of complementary providers and expanded sites has been documented in the United States; however, there is limited evidence in geographies outside the United States. To address this gap, we conducted a systematic literature review to identify studies that evaluated vaccination by complementary providers and/or at expanded sites outside of the United States. Of 943 identified records, 18 met our inclusion criteria and were conducted in Australia (4), Canada (6), the United Kingdom (3), Peru (2), Cameroon (1), or in multiple geographies (2). All studies demonstrated that expanding provider types and sites could positively impact vaccine uptake and/or provide additional benefits.
疫苗接种是一项成功的公共卫生干预措施;然而,由于疫苗接种率不足,疫苗可预防疾病仍然构成全球健康风险。扩大“替代”或补充医疗保健提供者进行疫苗接种的权限,以及批准更多非临床疫苗接种地点,可能会改善疫苗的可及性和接种率。补充医疗保健提供者和扩大接种地点的价值在美国已有记录;然而,在美国以外地区,相关证据有限。为了填补这一空白,我们进行了一项系统的文献综述,以确定评估美国以外地区补充医疗保健提供者和/或在扩大地点进行疫苗接种的研究。在943条检索到的记录中,有18项符合我们的纳入标准,这些研究分别在澳大利亚(4项)、加拿大(6项)、英国(3项)、秘鲁(2项)、喀麦隆(1项)或多个地区(2项)开展。所有研究均表明,扩大提供者类型和接种地点可对疫苗接种率产生积极影响和/或带来其他益处。